Skip to main content
Loading

BIO Seed-Stage Spotlight on Tech Transfer, Part 2

October 15, 2024
Venetian Room
BIO has collaborated with a set of programs focused on entrepreneur development to curate an afternoon of seed-stage company pitches from promising new companies ready to pursue investment or partnering discussions. BIO has worked with CLS’s Fast Program, NYU Endless Frontier, SPARK at Stanford, Tulane University School of Medicine, UCSF Innovation Ventures, and WARF to source these exciting new companies working on the next generation of medicines.​
Speakers
Eileen McCullough, CEO - Tiller Therapeutics, Inc.
Sue Wallace - PhD, Chief Executive Officer - Voximetry
Mike Galvin, Co-Founder - LivAi
Lauren Tyra - PhD, CEO - Gregor Diagnostics
Scott Thacher - PhD, CEO - Orphagen Pharmaceuticals
Sudip (Deep) Chakrabortty - MBA, Co-Founder and CEO - BCN Biosciences
Andrew Rudd - PhD, Co-Founder and CEO - Palm Therapeutics
Craig Ramirez - PhD, Founder and CEO - Tezcat Biosciences

DOUBLE HELIX SPONSOR

HELIX SPONSOR

PREMIER SPONSOR

CONFERENCE SPONSORS